| Title : CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells - Feng_2018_Biomed.Pharmacother_107_1496 |
| Author(s) : Feng X , Zhang D , Li X , Ma S , Zhang C , Wang J , Li Y , Liang L , Zhang P , Qu Y , Zhang Z , Yang Z , Xiang Y , Zhang W , Wang S , Shao W , Wang W |
| Ref : Biomed Pharmacother , 107 :1496 , 2018 |
| Abstract : Feng_2018_Biomed.Pharmacother_107_1496 |
| ESTHER : Feng_2018_Biomed.Pharmacother_107_1496 |
| PubMedSearch : Feng_2018_Biomed.Pharmacother_107_1496 |
| PubMedID: 30257367 |
Feng X, Zhang D, Li X, Ma S, Zhang C, Wang J, Li Y, Liang L, Zhang P, Qu Y, Zhang Z, Yang Z, Xiang Y, Zhang W, Wang S, Shao W, Wang W (2018)
CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells
Biomed Pharmacother
107 :1496
Feng X, Zhang D, Li X, Ma S, Zhang C, Wang J, Li Y, Liang L, Zhang P, Qu Y, Zhang Z, Yang Z, Xiang Y, Zhang W, Wang S, Shao W, Wang W (2018)
Biomed Pharmacother
107 :1496